Abstract
BACKGROUND- our study was aimed to know does Naltrexone used in opioid-dependent patient has any relation with the onset of depression. METHOD- Naltrexone was given to 30 opioid-dependent patients who had undergone inpatient detoxication with no underlying psychiatric comorbidity at baseline. HAM-D was applied at 2,4,6 weeks post Naltrexone initiation. RESULTS: Our study showed that at 2 weeks, 60% of patients showed depressive symptoms out of which 37% met the criteria for mild depressive disorder and 23% met the criteria for moderate to severe depression. At 4 and 6 weeks, majority continued to be depressive while only 3% of the patients showed improvement in depressive features. CONCLUSION: From our study, we concluded that a positive correlation was found between Naltrexone and Depression in Opioid users
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
